CANADIAN IMMUNO-ONCOLOGY 2022 HYBRID CONFERENCE 

The Canadian Immuno-Oncology Conference 2022 is a one-day hybrid event (in-person & digital) held in Eastern Standard Time. The meeting will cover a variety of important topics examining advances in immuno-oncology and will also explore topics that pertain to clinical practice, adverse event management and the pharmacoeconomics of novel therapies.

calendarFriday, September 30, 2022

Local Time

  • Timezone: America/Los_Angeles
  • Date: Friday, September 30, 2022
  • Time: 5:00 am - 2:00 pm

Join Us Live In Person
at the
BMO Institute for Learning, Toronto

Registration for Healthcare professionals can be completed below. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at kelly@oncologyeducation.ca for registration and sponsorship opportunities.

Buy Tickets

In Person & Virtual Options Below:

Book Event

In person - Physicians CAD $189

BMO Institute for Learning, Toronto

Available Tickets: 93
The In person - Physicians ticket is sold out. You can try another ticket or another date.
In person - Nurses, Pharmacists, Other Allied Healthcare Professionals CAD $109

BMO Institute for Learning, Toronto

Available Tickets: 93
The In person - Nurses, Pharmacists, Other Allied Healthcare Professionals ticket is sold out. You can try another ticket or another date.
In person - Students and Residents CAD $49

BMO Institute for Learning, Toronto

Available Tickets: 93
The In person - Students and Residents ticket is sold out. You can try another ticket or another date.
Virtual - Physicians CAD $79
Available Tickets: 93
The Virtual - Physicians ticket is sold out. You can try another ticket or another date.
Virtual - Nurses, Pharmacists, Other Allied Healthcare Professionals CAD $59
Available Tickets: 93
The Virtual - Nurses, Pharmacists, Other Allied Healthcare Professionals ticket is sold out. You can try another ticket or another date.
Virtual - Students and Residents CAD $39
Available Tickets: 93
The Virtual - Students and Residents ticket is sold out. You can try another ticket or another date.

Scientific Agenda

Times listed are EST

7:00am – 8:00am 

Registration and Breakfast Buffet

8:00am – 8:15am

Welcome Address by Chairs – Dr. Parneet Cheema & Dr. Michael Smylie

8:15am – 9:00am

Breakfast Symposium: TBA

9:00am – 9:45am

Immunotherapy – Dr. Jason Luke

9:45am – 10:10am

GI Updates

10:10am – 10:30am

Networking Break & Sponsor Exhibits

10:30am – 10:55am

Cardiac Toxicity – Dr. Paaladinesh Thavendiranathan

10:55am – 11:20am

Dermatologic Toxicities – Dr. Tom Salopek

11:20am – 11:45am

Breast Cancer – Dr. Dave Cescon

11:45am – 12:10pm

Lung Cancer – Dr. Natasha Leighl

12:10pm – 12:40pm

Lunch Break

12:40pm – 1:25pm

AstraZeneca Lunch Symposium: TBA

1:25pm – 1:50pm

Genitourinary (GU) – Dr. Christian Kollmansberger

1:50pm – 2:15pm

TBA

2:15pm – 2:35pm

Networking Break & Sponsor Exhibits

2:35pm – 3:00pm

Biomarkers – Dr. Anna Spreafico

3:00pm – 3:25pm

Drug Development Beyond PD1 and CTLA4

3:25pm – 3:40pm

Closing Remarks by Chairs – Dr. Parneet Cheema & Dr. Michael Smylie

personAbout the Faculty

Dr. Parneet Cheema

Conference Chair

Dr. Parneet Cheema is an Assistant Professor at the University of Toronto and Medical Oncologist at the William Osler Health System with a focus in thoracic, and skin malignancies. Dr. Cheema completed her undergraduate medical training at the University of Calgary, followed by Internal Medicine, and Medical Oncology training at the University of Toronto. Dr. Cheema also completed a Master’s degree in Biotechnology from the University of Toronto. She is the Head of Cancer Research at William Osler Health System and has been principle investigator and on global steering committees for clinical trials in the areas of melanoma and NSCLC using immunotherapies and targeted therapy. She began the Osler Immunotherapy for Cancer Program that focuses on management of immune related adverse events and patient education.

Dr. Michael Smylie

Conference Chair

Dr. Michael Smylie is Medical Oncologist at the Cross Cancer Institute in Edmonton, Alberta.

He holds an academic appointment as Professor, Department of Oncology, University of Alberta, Edmonton.

Dr. Michael Smylie is the past Site Leader for the Clinical Trials Committee, Cross Cancer Institute and past leader of the National Canada Institute of Cancer (NCIC) melanoma group.

Dr. Smylie has chaired several National Melanoma meetings and is the past chair of the Canadian Melanoma Conference.

Sponsorship

PLATINUM

AstraZeneca Logo

GOLD

Merck Logo

SILVER

BMS Logo
Roche Logo